Literature DB >> 9704402

Effective therapy for hepatic M. Osler with systemic hypercirculation by ligation of the hepatic artery and subsequent liver transplantation.

U P Neumann1, M Knoop, J M Langrehr, H Keck, W O Bechstein, H Lobeck, T Vogel, P Neuhaus.   

Abstract

Hereditary hemorrhagic teleangiectasia, or M. Osler (Osler-Weber-Rendu disease), is an autosomal dominant, systemic fibrovascular dysplasia. This may lead to increased liver blood flow from arteriovenous fistulas. A 45-year-old woman with a known M. Osler was admitted for liver transplantation. On admission, exertional dyspnea was the predominant symptom. Radiological investigations revealed multiple intrahepatic arteriovenous fistulas and consecutive high-output heart failure. Laboratory findings revealed remarkably elevated bilirubin and alkaline phosphatase. To alleviate the high-output cardiac failure, the hepatic artery was ligated. Fourteen months later, the patient presented again with increased levels of bilirubin and recurrent bleeding episodes from esophageal varices grade IV. The patient underwent liver transplantation and post-transplant recovery was excellent. A hyperdynamic circulatory state due to a hepatic M. Osler has been treated in several cases by ligation or embolization of the hepatic artery. This procedure, however, is recommended only for patients with normal liver function and carries a considerably risk of bile duct necrosis.

Entities:  

Mesh:

Year:  1998        PMID: 9704402     DOI: 10.1007/s001470050152

Source DB:  PubMed          Journal:  Transpl Int        ISSN: 0934-0874            Impact factor:   3.782


  6 in total

1.  Successful liver transplantation for Rendu-Weber-Osler disease, a single centre experience.

Authors:  Murat Cag; Maxime Audet; Anne-Catherine Saouli; Murad Odeh; Bernard Ellero; Tullio Piardi; Marie-Lorraine Woehl-Jaeglé; Jacques Cinqualbre; Philippe Wolf
Journal:  Hepatol Int       Date:  2011-02-17       Impact factor: 6.047

2.  Liver transplantation for hereditary hemorrhagic telangiectasia: Report of the European liver transplant registry.

Authors:  Jan Lerut; Giuseppe Orlando; René Adam; Carlo Sabbà; Robert Pfitzmann; Jurgen Klempnauer; Jacques Belghiti; Jacques Pirenne; Thierry Thevenot; Christian Hillert; Colin M Brown; Dominique Gonze; Vincent Karam; Olivier Boillot
Journal:  Ann Surg       Date:  2006-12       Impact factor: 12.969

3.  Hepatic artery embolization for treatment of patients with hereditary hemorrhagic telangiectasia and symptomatic hepatic vascular malformations.

Authors:  Ajay Chavan; Martin Caselitz; Karl-Friedrich Gratz; Joachim Lotz; Timm Kirchhoff; Plinio Piso; Siegfried Wagner; Michael Manns; Michael Galanski
Journal:  Eur Radiol       Date:  2004-08-17       Impact factor: 5.315

4.  Treatment of high output cardiac failure by flow-adapted hepatic artery banding (FHAB) in patients with hereditary hemorrhagic telangiectasia.

Authors:  A Koscielny; W A Willinek; A Hirner; M Wolff
Journal:  J Gastrointest Surg       Date:  2007-11-20       Impact factor: 3.452

5.  Right hemihepatectomy combined with ligation of the common hepatic artery and gastroduodenal artery for the treatment of intrahepatic HHT: A case report.

Authors:  Jifeng Xiang; Wei Xie; Cuncheng Zhang; Huaizhi Wang
Journal:  Front Surg       Date:  2022-08-09

Review 6.  Perioperative Complications and Long-Term Follow-Up of Liver Transplantation in Hemorrhagic Hereditary Telangiectasia: Report of Three Cases and Systematic Review.

Authors:  Antoni Riera-Mestre; Pau Cerdà; Yoelimar Carolina Guzmán; Adriana Iriarte; Alba Torroella; José María Mora-Luján; Jose Castellote; Amelia Hessheimer; Constantino Fondevila; Laura Lladó
Journal:  J Clin Med       Date:  2022-09-24       Impact factor: 4.964

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.